Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 26 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 10238642

    Methods for treating neurogenic orthostatic hypotension

    Theravance Biopharma R&D IP, LLC · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  2. US 10233450

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  3. US 10231929

    Solid dispersion

    Takeda Pharmaceutical Company Limited · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  4. US 10226426

    Suspension containing nano-cocrystal and manufacturing method

    Takeda Pharmaceutical Company Limited · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  5. US 10221414

    Compositions for modulating C9ORF72 expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  6. US 10214721

    Method for making culture medium

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  7. US 10206875

    Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells

    Northwestern University · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  8. US 10211414

    Phosphorescent tetradentate metal complexes having modified emission spectra

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  9. US 10201547

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  10. US 10202603

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  11. US 10196596

    Engineered lumenized vascular networks and support matrix

    National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  12. US 10195612

    Small particle compositions and associated methods

    Primet Precision Materials, Inc. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  13. WO 2019016609

    TRAITEMENT DE LÉSIONS NON INFLAMMATOIRES

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 24, 2019 · Expires Jan 19, 2039

    granted

  14. US 10183011

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  15. US 10184125

    Modulation of TMPRSS6 expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  16. US 10174085

    Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  17. US 10172836

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy

    PTC THERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  18. US 10167314

    Methods of treating depression and other related diseases

    Northwestern University · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  19. US 10149912

    Dehydrated hydrogel inclusion complex

    Indivior UK Limited · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  20. US 10143760

    Liver-specific constructs, factor VIII expression cassettes and methods of use thereof

    Sangamo Therapeutics, Inc. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  21. US 10143219

    Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  22. US 10138482

    Compositions for modulating C9ORF72 expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  23. US 10137190

    Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  24. US 10125172

    Conformationally stabilized RSV pre-fusion F proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.